Cargando…

Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice

BACKGROUND: Schisandrin B (Sch B), a dibenzocyclooctadiene compound, is isolated from schisandrae fructus (SF). This study was conducted to compare the time- and dose-response between Sch B- and SF oil (SFO)-induced changes in hepatic and serum parameters in mice. METHODS: Institute of Cancer Resear...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yi, Pan, Si-Yuan, Zhou, Shu-Feng, Wang, Xiao-Yan, Sun, Nan, Zhu, Pei-Li, Chu, Zhu-Sheng, Yu, Zhi-Ling, Ko, Kam-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179757/
https://www.ncbi.nlm.nih.gov/pubmed/25278745
http://dx.doi.org/10.2147/DDDT.S67518
_version_ 1782337144479547392
author Zhang, Yi
Pan, Si-Yuan
Zhou, Shu-Feng
Wang, Xiao-Yan
Sun, Nan
Zhu, Pei-Li
Chu, Zhu-Sheng
Yu, Zhi-Ling
Ko, Kam-Ming
author_facet Zhang, Yi
Pan, Si-Yuan
Zhou, Shu-Feng
Wang, Xiao-Yan
Sun, Nan
Zhu, Pei-Li
Chu, Zhu-Sheng
Yu, Zhi-Ling
Ko, Kam-Ming
author_sort Zhang, Yi
collection PubMed
description BACKGROUND: Schisandrin B (Sch B), a dibenzocyclooctadiene compound, is isolated from schisandrae fructus (SF). This study was conducted to compare the time- and dose-response between Sch B- and SF oil (SFO)-induced changes in hepatic and serum parameters in mice. METHODS: Institute of Cancer Research (ICR) mice were given a single oral dose of Sch B (0.125–2 g/kg) or SFO (0.3–5 g/kg). Serum alanine aminotransferase (ALT) activity, hepatic malondialdehyde, and triglyceride (TG) levels were measured at increasing time intervals within 6–120 hours postdosing. RESULTS: Serum ALT activity was elevated by 60%, with maximum effect (E(max)) =45.77 U/L and affinity (K(D)) =1.25 g/kg at 48–96 hours following Sch B, but not SFO, treatment. Sch B and SFO treatments increased hepatic malondialdehyde level by 70% (E(max) =2.30 nmol/mg protein and K(D) =0.41 g/kg) and 22% (E(max) =1.42 nmol/mg protein and K(D) =2.56 g/kg) at 72 hours postdosing, respectively. Hepatic index was increased by 16%–60% (E(max) =11.01, K(D) =0.68 g/kg) and 8%–32% (E(max) =9.88, K(D) =4.47 g/kg) at 12–120 hours and 24–120 hours after the administration of Sch B and SFO, respectively. Hepatic TG level was increased by 40%–158% and 35%–85%, respectively, at 12–96 hours and 6–48 hours after Sch B and SFO treatment, respectively. The values of E(max) and K(D) for Sch B/SFO-induced increase in hepatic TG were estimated to be 22.94/15.02 μmol/g and 0.78/3.03 g/kg, respectively. Both Sch B and SFO increased serum TG (up to 427% and 123%, respectively), with the values of E(max) =5.50/4.60 mmol/L and K(D) =0.43/2.84 g/kg, respectively. CONCLUSION: The findings indicated that Sch B/SFO-induced increases in serum/hepatic parameters occurred in a time-dependent manner, with the time of onset being serum TG level < hepatic TG level < hepatic index < serum ALT activity. However, the time of recovery of these parameters to normal values varied as follow: serum TG level < hepatic TG level and liver injury < hepatic index. The E(max) and affinity of Sch B on tissue/enzyme/receptor were larger than those of SFO.
format Online
Article
Text
id pubmed-4179757
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-41797572014-10-02 Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice Zhang, Yi Pan, Si-Yuan Zhou, Shu-Feng Wang, Xiao-Yan Sun, Nan Zhu, Pei-Li Chu, Zhu-Sheng Yu, Zhi-Ling Ko, Kam-Ming Drug Des Devel Ther Original Research BACKGROUND: Schisandrin B (Sch B), a dibenzocyclooctadiene compound, is isolated from schisandrae fructus (SF). This study was conducted to compare the time- and dose-response between Sch B- and SF oil (SFO)-induced changes in hepatic and serum parameters in mice. METHODS: Institute of Cancer Research (ICR) mice were given a single oral dose of Sch B (0.125–2 g/kg) or SFO (0.3–5 g/kg). Serum alanine aminotransferase (ALT) activity, hepatic malondialdehyde, and triglyceride (TG) levels were measured at increasing time intervals within 6–120 hours postdosing. RESULTS: Serum ALT activity was elevated by 60%, with maximum effect (E(max)) =45.77 U/L and affinity (K(D)) =1.25 g/kg at 48–96 hours following Sch B, but not SFO, treatment. Sch B and SFO treatments increased hepatic malondialdehyde level by 70% (E(max) =2.30 nmol/mg protein and K(D) =0.41 g/kg) and 22% (E(max) =1.42 nmol/mg protein and K(D) =2.56 g/kg) at 72 hours postdosing, respectively. Hepatic index was increased by 16%–60% (E(max) =11.01, K(D) =0.68 g/kg) and 8%–32% (E(max) =9.88, K(D) =4.47 g/kg) at 12–120 hours and 24–120 hours after the administration of Sch B and SFO, respectively. Hepatic TG level was increased by 40%–158% and 35%–85%, respectively, at 12–96 hours and 6–48 hours after Sch B and SFO treatment, respectively. The values of E(max) and K(D) for Sch B/SFO-induced increase in hepatic TG were estimated to be 22.94/15.02 μmol/g and 0.78/3.03 g/kg, respectively. Both Sch B and SFO increased serum TG (up to 427% and 123%, respectively), with the values of E(max) =5.50/4.60 mmol/L and K(D) =0.43/2.84 g/kg, respectively. CONCLUSION: The findings indicated that Sch B/SFO-induced increases in serum/hepatic parameters occurred in a time-dependent manner, with the time of onset being serum TG level < hepatic TG level < hepatic index < serum ALT activity. However, the time of recovery of these parameters to normal values varied as follow: serum TG level < hepatic TG level and liver injury < hepatic index. The E(max) and affinity of Sch B on tissue/enzyme/receptor were larger than those of SFO. Dove Medical Press 2014-09-19 /pmc/articles/PMC4179757/ /pubmed/25278745 http://dx.doi.org/10.2147/DDDT.S67518 Text en © 2014 Zhang et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Zhang, Yi
Pan, Si-Yuan
Zhou, Shu-Feng
Wang, Xiao-Yan
Sun, Nan
Zhu, Pei-Li
Chu, Zhu-Sheng
Yu, Zhi-Ling
Ko, Kam-Ming
Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice
title Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice
title_full Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice
title_fullStr Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice
title_full_unstemmed Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice
title_short Time and dose relationships between schisandrin B- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice
title_sort time and dose relationships between schisandrin b- and schisandrae fructus oil-induced hepatotoxicity and the associated elevations in hepatic and serum triglyceride levels in mice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179757/
https://www.ncbi.nlm.nih.gov/pubmed/25278745
http://dx.doi.org/10.2147/DDDT.S67518
work_keys_str_mv AT zhangyi timeanddoserelationshipsbetweenschisandrinbandschisandraefructusoilinducedhepatotoxicityandtheassociatedelevationsinhepaticandserumtriglyceridelevelsinmice
AT pansiyuan timeanddoserelationshipsbetweenschisandrinbandschisandraefructusoilinducedhepatotoxicityandtheassociatedelevationsinhepaticandserumtriglyceridelevelsinmice
AT zhoushufeng timeanddoserelationshipsbetweenschisandrinbandschisandraefructusoilinducedhepatotoxicityandtheassociatedelevationsinhepaticandserumtriglyceridelevelsinmice
AT wangxiaoyan timeanddoserelationshipsbetweenschisandrinbandschisandraefructusoilinducedhepatotoxicityandtheassociatedelevationsinhepaticandserumtriglyceridelevelsinmice
AT sunnan timeanddoserelationshipsbetweenschisandrinbandschisandraefructusoilinducedhepatotoxicityandtheassociatedelevationsinhepaticandserumtriglyceridelevelsinmice
AT zhupeili timeanddoserelationshipsbetweenschisandrinbandschisandraefructusoilinducedhepatotoxicityandtheassociatedelevationsinhepaticandserumtriglyceridelevelsinmice
AT chuzhusheng timeanddoserelationshipsbetweenschisandrinbandschisandraefructusoilinducedhepatotoxicityandtheassociatedelevationsinhepaticandserumtriglyceridelevelsinmice
AT yuzhiling timeanddoserelationshipsbetweenschisandrinbandschisandraefructusoilinducedhepatotoxicityandtheassociatedelevationsinhepaticandserumtriglyceridelevelsinmice
AT kokamming timeanddoserelationshipsbetweenschisandrinbandschisandraefructusoilinducedhepatotoxicityandtheassociatedelevationsinhepaticandserumtriglyceridelevelsinmice